# KCNJ11

## Overview
The KCNJ11 gene encodes the potassium inwardly rectifying channel subfamily J member 11 (Kir6.2), a critical component of the ATP-sensitive potassium (K_ATP) channel. This transmembrane protein plays a pivotal role in linking cellular metabolism to electrical activity, particularly in pancreatic beta cells and neurons. The K_ATP channel, composed of Kir6.2 and sulfonylurea receptor 1 (SUR1) subunits, regulates insulin secretion by responding to changes in intracellular ATP levels. Mutations in KCNJ11 can lead to significant clinical conditions, including neonatal diabetes and congenital hyperinsulinism, by altering the channel's ATP sensitivity (Flanagan2006Mutations; Hattersley2005Activating). The gene's importance in glucose homeostasis and its involvement in various forms of diabetes underscore its clinical significance (Weedon2016From).

## Structure
The KCNJ11 gene encodes the Kir6.2 protein, a subunit of the ATP-sensitive potassium (K_ATP) channel. The primary structure of Kir6.2 consists of approximately 390 amino acids. Its secondary structure includes transmembrane helices that are crucial for its function as a channel. The tertiary structure of Kir6.2 involves a pore-forming domain, which is essential for its role in regulating potassium flow across the cell membrane. In terms of quaternary structure, Kir6.2 forms a tetramer, associating with SUR1 subunits to create the functional K_ATP channel complex. This complex is vital for linking cellular metabolism to electrical activity, particularly in pancreatic beta cells and neurons (Vedovato2016Neonatal).

Post-translational modifications of Kir6.2 include phosphorylation, which can influence the channel's activity and regulation. These structural features and modifications are critical for the proper functioning of the K_ATP channel, and mutations in KCNJ11 can lead to significant clinical conditions such as neonatal diabetes and congenital hyperinsulinism by altering the channel's ATP sensitivity (Vedovato2016Neonatal).

## Function
The KCNJ11 gene encodes the Kir6.2 subunit of the ATP-sensitive potassium (K_ATP) channel, which is crucial for insulin secretion in pancreatic beta cells. This channel is an octameric complex composed of four Kir6.2 subunits and four sulfonylurea receptor 1 (SUR1) subunits. In healthy human cells, the K_ATP channel regulates insulin secretion by linking cellular metabolism to membrane potential. When glucose enters the beta cell, it is metabolized, increasing intracellular ATP levels. ATP binds to Kir6.2, causing the K_ATP channel to close, which results in the depolarization of the beta cell membrane. This depolarization opens voltage-dependent calcium channels, increasing intracellular calcium levels and triggering insulin exocytosis (Gloyn2004Activating; He2020Continuous).

The K_ATP channel's activity is essential for maintaining glucose homeostasis, as it helps regulate the release of insulin in response to blood glucose levels. When plasma glucose levels are low, the cytosolic ATP/ADP ratio decreases, leading to potassium ion efflux through K_ATP channels, maintaining the membrane potential at approximately -70 mV, which prevents calcium entry and suppresses insulin secretion (Weedon2016From). The KCNJ11 gene, through its product Kir6.2, is essential for this process, as it forms the potassium-selective pore of the K_ATP channel complex (Weedon2016From).

## Clinical Significance
Mutations in the KCNJ11 gene, which encodes the Kir6.2 subunit of the ATP-sensitive potassium (K_ATP) channel, are associated with several forms of diabetes and neurological conditions. Activating mutations in KCNJ11 are a common cause of neonatal diabetes, which can be either permanent or transient. These mutations reduce the sensitivity of the K_ATP channel to ATP, leading to impaired insulin secretion and hyperglycemia (Flanagan2006Mutations; Hattersley2005Activating). Approximately 40-64% of patients diagnosed with diabetes before six months of age have KCNJ11 mutations (Hattersley2005Activating).

Specific mutations, such as R201H and V59M, are linked to distinct clinical phenotypes. The R201H mutation is often associated with isolated diabetes, while the V59M mutation is linked to intermediate DEND syndrome, characterized by developmental delay, epilepsy, and neonatal diabetes (Flanagan2006Mutations; Gloyn2006KCNJ11). Some patients with KCNJ11 mutations can transition from insulin injections to sulfonylurea tablets, which can improve glycemic control (Flanagan2006Mutations).

In addition to diabetes, KCNJ11 mutations can cause neurological features such as developmental delay, muscle weakness, and epilepsy, often grouped under DEND syndrome (Hattersley2005Activating; Gloyn2006KCNJ11). The variability in phenotypic expression suggests that other genetic or environmental factors may influence the clinical presentation (Flanagan2006Mutations).

## Interactions
The KCNJ11 gene encodes the Kir6.2 protein, which is a critical component of the ATP-sensitive potassium (K_ATP) channel. This channel is a complex formed by the interaction of Kir6.2 with the sulfonylurea receptor (SUR) subunits, specifically SUR1, to regulate insulin secretion in pancreatic β-cells (Hattersley2005Activating). The K_ATP channel's activity is modulated by nucleotides such as ATP and ADP, which bind to Kir6.2 and influence its open or closed state. ATP binding typically results in channel closure, thereby promoting insulin release (Hattersley2005Activating).

Mutations in KCNJ11 can alter these interactions, leading to various forms of diabetes. Gain-of-function mutations reduce ATP sensitivity, increasing K_ATP current and inhibiting insulin secretion, which is linked to neonatal diabetes (Hattersley2005Activating). Loss-of-function mutations, such as the S118L mutation, impair the surface expression of the K_ATP channel by disrupting the assembly and trafficking of Kir6.2 and SUR1 subunits, affecting insulin regulation (Vedovato2024A).

The KCNJ11 protein also participates in protein-protein interaction networks, where it is directly adjacent to insulin (INS) in a network analysis, highlighting its role in diabetes-related pathways (Usman2019Identification).


## References


[1. (Gloyn2004Activating) Anna L. Gloyn, Ewan R. Pearson, Jennifer F. Antcliff, Peter Proks, G. Jan Bruining, Annabelle S. Slingerland, Neville Howard, Shubha Srinivasan, José M.C.L. Silva, Janne Molnes, Emma L. Edghill, Timothy M. Frayling, I. Karen Temple, Deborah Mackay, Julian P.H. Shield, Zdenek Sumnik, Adrian van Rhijn, Jerry K.H. Wales, Penelope Clark, Shaun Gorman, Javier Aisenberg, Sian Ellard, Pål R. Njølstad, Frances M. Ashcroft, and Andrew T. Hattersley. Activating mutations in the gene encoding the atp-sensitive potassium-channel subunit kir6.2 and permanent neonatal diabetes. New England Journal of Medicine, 350(18):1838–1849, April 2004. URL: http://dx.doi.org/10.1056/nejmoa032922, doi:10.1056/nejmoa032922. This article has 913 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1056/nejmoa032922)

[2. (Flanagan2006Mutations) S. E. Flanagan, E. L. Edghill, A. L. Gloyn, S. Ellard, and A. T. Hattersley. Mutations in kcnj11, which encodes kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia, 49(6):1190–1197, April 2006. URL: http://dx.doi.org/10.1007/s00125-006-0246-z, doi:10.1007/s00125-006-0246-z. This article has 176 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-006-0246-z)

[3. (Hattersley2005Activating) Andrew T. Hattersley and Frances M. Ashcroft. Activating mutations in kir6.2 and neonatal diabetes. Diabetes, 54(9):2503–2513, September 2005. URL: http://dx.doi.org/10.2337/diabetes.54.9.2503, doi:10.2337/diabetes.54.9.2503. This article has 339 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.2337/diabetes.54.9.2503)

[4. (Gloyn2006KCNJ11) Anna L Gloyn, Catherine Diatloff-Zito, Emma L Edghill, Christine Bellanné-Chantelot, Sylvie Nivot, Régis Coutant, Sian Ellard, Andrew T Hattersley, and Jean Jacques Robert. Kcnj11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. European Journal of Human Genetics, 14(7):824–830, May 2006. URL: http://dx.doi.org/10.1038/sj.ejhg.5201629, doi:10.1038/sj.ejhg.5201629. This article has 124 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.ejhg.5201629)

[5. (Vedovato2024A) Natascia Vedovato, Maria V. Salguero, Siri Atma W. Greeley, Christine H. Yu, Louis H. Philipson, and Frances M. Ashcroft. A loss-of-function mutation in kcnj11 causing sulfonylurea-sensitive diabetes in early adult life. Diabetologia, 67(5):940–951, February 2024. URL: http://dx.doi.org/10.1007/s00125-024-06103-w, doi:10.1007/s00125-024-06103-w. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-024-06103-w)

[6. (Weedon2016From) Michael N. Weedon and Peter Light. From Association to Function: KCNJ11 and ABCC8, pages 363–377. Springer International Publishing, 2016. URL: http://dx.doi.org/10.1007/978-3-319-01574-3_17, doi:10.1007/978-3-319-01574-3_17. This article has 0 citations.](https://doi.org/10.1007/978-3-319-01574-3_17)

[7. (He2020Continuous) Binbin He, Xia Li, and Zhiguang Zhou. Continuous spectrum of glucose dysmetabolism due to the <scp>kcnj11</scp> gene mutation—case reports and review of the literature. Journal of Diabetes, 13(1):19–32, October 2020. URL: http://dx.doi.org/10.1111/1753-0407.13114, doi:10.1111/1753-0407.13114. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/1753-0407.13114)

[8. (Vedovato2016Neonatal) Natascia Vedovato, Edward Cliff, Peter Proks, Varadarajan Poovazhagi, Sarah E. Flanagan, Sian Ellard, Andrew T. Hattersley, and Frances M. Ashcroft. Neonatal diabetes caused by a homozygous kcnj11 mutation demonstrates that tiny changes in atp sensitivity markedly affect diabetes risk. Diabetologia, 59(7):1430–1436, April 2016. URL: http://dx.doi.org/10.1007/s00125-016-3964-x, doi:10.1007/s00125-016-3964-x. This article has 30 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-016-3964-x)

[9. (Usman2019Identification) Muhammad Syafiuddin Usman, Wisnu Ananta Kusuma, Farit Mochamad Afendi, and Rudi Heryanto. Identification of significant proteins associated with diabetes mellitus using network analysis of protein-protein interactions. Computer Engineering and Applications Journal, 8(1):41–52, February 2019. URL: http://dx.doi.org/10.18495/COMENGAPP.V8I1.283, doi:10.18495/comengapp.v8i1.283. This article has 9 citations.](https://doi.org/10.18495/COMENGAPP.V8I1.283)